The table below shows HAEMONETICS CORP's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
Revenue
$1.33B
$1.36B
$1.31B
$1.17B
$993.20M
$870.46M
Cost of revenue
$546.44M
$611.87M
$617.51M
$553.56M
$487.69M
$472.63M
Gross profit
$787.59M
$748.96M
$691.55M
$615.10M
$505.50M
$397.84M
R&D
$59.77M
$62.72M
$54.44M
$50.13M
$46.80M
$32.86M
HAE annual revenue (10-K history)
HAEMONETICS CORP reported annual revenue of $1.33B for fiscal year 2026. That is down 2.0% from $1.36B in fiscal 2025. Over the 10 fiscal years shown, annual revenue grew from $886.12M (FY 2017) to $1.33B. Figures come from the company's audited annual reports as filed with the SEC.
